checkAd
SRH AlsterResearch AG Update: CompuGroup Medical SE - Reaction to Q1 results overdone; PT up; Upgrade to BUY

SRH AlsterResearch AG Update: CompuGroup Medical SE - Reaction to Q1 results overdone; PT up; Upgrade to BUY

Nachrichtenquelle: AlsterResearch AG
10.05.2021, 12:43  |  146   |   |   

CompuGroup reported a decent Q4 2020, with full-year revenues and profitability coming in line with its updated guidance, which demonstrates the company’s strong resilience, even in an uncertain year.

CompuGroup Medical Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de



0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

SRH AlsterResearch AG Update: CompuGroup Medical SE - Reaction to Q1 results overdone; PT up; Upgrade to BUY CompuGroup reported a decent Q4 2020, with full-year revenues and profitability coming in line with its updated guidance, which demonstrates the company’s strong resilience, even in an uncertain year. For 2021, the group targets sales of EUR 1bn – EUR_1.04bn (organic growth: 4%-8% yoy), with all the segments guided to report higher revenue growth (at the midpoint).

Community

Nachrichten des Autors

Titel
Titel